Case report: 5-Fluorouracil treatment in patient with an important partial DPD deficiency

Esophageal cancer is a cancer with poor prognosis and the standard 1(st) line treatment for metastatic or recurrent EC is systemic chemotherapy with doublet chemotherapy based on platinum and 5-fluorouracil (5-FU). However, 5-FU could be a source of severe treatment-related toxicities due to deficie...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitt, Antonin, Royer, Bernard, Boidot, Romain, Berthier, Joseph, Ghiringhelli, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319454/
https://www.ncbi.nlm.nih.gov/pubmed/37409256
http://dx.doi.org/10.3389/fonc.2023.1187052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319454/
https://www.ncbi.nlm.nih.gov/pubmed/37409256
http://dx.doi.org/10.3389/fonc.2023.1187052

Ejemplares similares